Unit Code 800093:
T3 (Triiodothyronine), Total, Serum
Useful For
Second-order testing for hyperthyroidism in patients with low thyroid
stimulating hormone (TSH) values and normal T4 levels
Diagnosis of T3 toxicosis
Clinical Information
Thyroid hormones regulate a number of developmental,
metabolic, and neural activities throughout the body. The 2 main
hormones secreted by the thyroid gland are thyroxine, which
contains 4 atoms of iodine (T4), and triiodothyronine (T3). T3 is
also produced by conversion (deiodination) of T4 in peripheral
tissues. Circulating levels of T4 are much greater than T3 levels,
but T3 is more metabolically active than T4, although its effect is
briefer.
Thyroid hormones circulate primarily bound to carrier proteins
(e.g., thyroid-binding globulin [TBG], albumin); a small fraction
circulates unbound (free). Only the free forms are metabolically
active. While both T3 and T4 are bound to TBG, T3 is bound less
firmly than T4. Total T3 consists of both the bound and unbound
fractions.
In hyperthyroidism both T4 and T3 levels are usually elevated,
but in a small subset of hyperthyroid patients only T3 is elevated
(T3 toxicosis).
In hypothyroidism T4 and T3 levels are decreased. T3 levels
are frequently low in sick or hospitalized euthyroid patients.
See "Thyroid Function Algorithm" in Special Instructions.
Reference Values
> or =1 year: 80-190 ng/dL
Interpretation
T3 values >180 ng/dL in adults or >200 ng/dL in children are
consistent with hyperthyroidism or increased thyroid hormone-
binding proteins.
Abnormal levels (high or low) of thyroid hormone-binding proteins
(primarily albumin and TBG) may cause abnormal T3
concentrations in euthyroid patients.
Cautions
T3 is not a reliable marker for hypothyroidism.
T3 is not useful for general screening of the population without a
clinical suspicion of hyperthyroidism.
Some patients who have been exposed to animal antigens, either
in the environment or as part of treatment or imaging procedures,
may have circulating antianimal antibodies present. These anti-
bodies may interfere with the assay reagents to produce unreliable
results.
Special Instructions and Forms
Clinical Reference
1. Hay ID, Klee GG: Linking medical needs and performance
goals: clinical and laboratory perspectives on thyroid disease.
Clin Chem 1993;39:1519-1524
2. Klee GG: Clinical usage recommendations and analytic
performance goals for total and free triiodothyronine
measurements. Clin Chem 1996;42:155-159


